March 12, 2020 / 2:00 PM / 16 days ago

BRIEF-Protalix Biotherapeutics Reports Q4 EPS Of $0.02

March 12 (Reuters) - Protalix Biotherapeutics Inc:

* PROTALIX BIOTHERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL AND BUSINESS RESULTS

* Q4 EARNINGS PER SHARE $0.02

* PROTALIX BIOTHERAPEUTICS - AT DECEMBER 31, 2019, CO HAD $17.8 MILLION IN CASH AND CASH EQUIVALENTS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below